These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 37489992)
1. Multicenter Randomized Trial Assessing MRI and Image-guided Biopsy for Suspected Prostate Cancer: The MULTIPROS Study. Wei C; Szewczyk-Bieda M; Bates AS; Donnan PT; Rauchhaus P; Gandy S; Ragupathy SKA; Singh P; Coll K; Serhan J; Wilson J; Nabi G Radiology; 2023 Jul; 308(1):e221428. PubMed ID: 37489992 [TBL] [Abstract][Full Text] [Related]
2. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study. Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P Eur Urol; 2021 Dec; 80(6):682-689. PubMed ID: 34465492 [TBL] [Abstract][Full Text] [Related]
3. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
4. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate? Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Ghai S; Perlis N; Atallah C; Jokhu S; Corr K; Lajkosz K; Incze PF; Zlotta AR; Jain U; Fleming H; Finelli A; van der Kwast TH; Haider MA Radiology; 2022 Nov; 305(2):390-398. PubMed ID: 35852425 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer. Ghai S; Klotz L; Pond GR; Kebabdjian M; Downes MR; Belanger EC; Moussa M; van der Kwast TH Radiology; 2024 Jul; 312(1):e231948. PubMed ID: 39012252 [TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy. Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121 [TBL] [Abstract][Full Text] [Related]
8. Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers. Yilmaz EC; Shih JH; Belue MJ; Harmon SA; Phelps TE; Garcia C; Hazen LA; Toubaji A; Merino MJ; Gurram S; Choyke PL; Wood BJ; Pinto PA; Turkbey B Radiology; 2023 May; 307(4):e221309. PubMed ID: 37129493 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis. Elwenspoek MMC; Sheppard AL; McInnes MDF; Merriel SWD; Rowe EWJ; Bryant RJ; Donovan JL; Whiting P JAMA Netw Open; 2019 Aug; 2(8):e198427. PubMed ID: 31390032 [TBL] [Abstract][Full Text] [Related]
10. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study. van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981 [TBL] [Abstract][Full Text] [Related]
11. Combination of Multiparametric Magnetic Resonance Imaging With Elastic-fusion Biopsy Has a High Sensitivity in Detecting Clinically Significant Prostate Cancer in Daily Practice. Cecchini S; Castellani D; Fabbietti P; Mazzucchelli R; Montironi R; Cecarini M; Carnevali F; Pierangeli T; Dellabella M; Ravasi E Clin Genitourin Cancer; 2020 Oct; 18(5):e501-e509. PubMed ID: 32147365 [TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
13. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer. Stabile A; Dell'Oglio P; Soligo M; De Cobelli F; Gandaglia G; Fossati N; Esposito A; Brembilla G; Karnes RJ; Montorsi F; Briganti A Eur Urol Oncol; 2021 Aug; 4(4):594-600. PubMed ID: 31204312 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective Study. Lughezzani G; Maffei D; Saita A; Paciotti M; Diana P; Buffi NM; Colombo P; Elefante GM; Hurle R; Lazzeri M; Guazzoni G; Casale P Eur Urol Focus; 2021 Sep; 7(5):1019-1026. PubMed ID: 33069624 [TBL] [Abstract][Full Text] [Related]
15. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial. Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519 [TBL] [Abstract][Full Text] [Related]
16. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer. Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122 [TBL] [Abstract][Full Text] [Related]
17. MRI-targeted biopsy for detecting prostate cancer: have the guidelines changed our practices and our prostate cancer detection rate? Baboudjian M; Bandelier Q; Gondran-Tellier B; Abdallah R; Michel F; Sichez PC; Di-Crocco E; Akiki A; Gaillet S; Delaporte V; Andre M; Daniel L; Karsenty G; Lechevallier E; Boissier R Int Urol Nephrol; 2020 Apr; 52(4):611-618. PubMed ID: 31786702 [TBL] [Abstract][Full Text] [Related]
18. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies. Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912 [TBL] [Abstract][Full Text] [Related]
19. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. Mazzone E; Stabile A; Pellegrino F; Basile G; Cignoli D; Cirulli GO; Sorce G; Barletta F; Scuderi S; Bravi CA; Cucchiara V; Fossati N; Gandaglia G; Montorsi F; Briganti A Eur Urol Oncol; 2021 Oct; 4(5):697-713. PubMed ID: 33358543 [TBL] [Abstract][Full Text] [Related]
20. Development of a nomogram combining multiparametric magnetic resonance imaging and PSA-related parameters to enhance the detection of clinically significant cancer across different region. Zhou Z; Liang Z; Zuo Y; Zhou Y; Yan W; Wu X; Ji Z; Li H; Hu M; Ma L Prostate; 2022 Apr; 82(5):556-565. PubMed ID: 35098557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]